Literature DB >> 12154198

Structure of the extracellular region of HER3 reveals an interdomain tether.

Hyun-Soo Cho1, Daniel J Leahy.   

Abstract

We have determined the 2.6 angstrom crystal structure of the entire extracellular region of human HER3 (ErbB3), a member of the epidermal growth factor receptor (EGFR) family. The structure consists of four domains with structural homology to domains found in the type I insulin-like growth factor receptor. The HER3 structure reveals a contact between domains II and IV that constrains the relative orientations of ligand-binding domains and provides a structural basis for understanding both multiple-affinity forms of EGFRs and conformational changes induced in the receptor by ligand binding during signaling. These results also suggest new therapeutic approaches to modulating the behavior of members of the EGFR family.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154198     DOI: 10.1126/science.1074611

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  158 in total

1.  Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand.

Authors:  Bing-Hao Luo; Timothy A Springer; Junichi Takagi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

2.  Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.

Authors:  Sashikanth Banappagari; Miriam Corti; Seth Pincus; Seetharama Satyanarayanajois
Journal:  J Biomol Struct Dyn       Date:  2012-06-26

Review 3.  The ERBB network: at last, cancer therapy meets systems biology.

Authors:  Yosef Yarden; Gur Pines
Journal:  Nat Rev Cancer       Date:  2012-07-12       Impact factor: 60.716

Review 4.  Roles for growth factors in cancer progression.

Authors:  Esther Witsch; Michael Sela; Yosef Yarden
Journal:  Physiology (Bethesda)       Date:  2010-04

5.  Structural basis for negative cooperativity in growth factor binding to an EGF receptor.

Authors:  Diego Alvarado; Daryl E Klein; Mark A Lemmon
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

Review 6.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

Review 7.  Molecular pathways: HER3 targeted therapy.

Authors:  Kinisha Gala; Sarat Chandarlapaty
Journal:  Clin Cancer Res       Date:  2014-02-11       Impact factor: 12.531

8.  Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martínez-Salazar
Journal:  J Mol Model       Date:  2012-10-23       Impact factor: 1.810

9.  Dynamic transition states of ErbB1 phosphorylation predicted by spatial stochastic modeling.

Authors:  Meghan McCabe Pryor; Shalini T Low-Nam; Adám M Halász; Diane S Lidke; Bridget S Wilson; Jeremy S Edwards
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

10.  Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.

Authors:  Jessica P Dawson; Mitchell B Berger; Chun-Chi Lin; Joseph Schlessinger; Mark A Lemmon; Kathryn M Ferguson
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.